Experimental analysis uncovers ESAT-6's role in cGAS/STING signaling and IFN responses in Mtb, highlighting immune evasion mechanisms.
Mycobacterium tuberculosis (Mtb) remains a global health threat due to its ability to subvert host immune responses. Emerging evidence suggests that Mtb infection induces the production of type I interferons (IFNs), during which cGAS directly binds to Mtb genomic DNA. Here, we demonstrate that ESAT-6, a secreted virulence factor of Mtb, potently induces type I interferon (IFN) responses through a cGAS/STING-dependent signaling axis. Genetic ablation and pharmacological inhibition of cGAS or STING abolished ESAT-6-induced IFN-β production. Mechanistically, ESAT-6 induces mitochondrial dysfunction, characterized by mitochondrial DNA (mtDNA) release and mitochondrial ROS (mtROS) production. Further investigation revealed that ESAT-6 triggers GSDMD cleavage, followed by the formation of GSDMD-NT. GSDMD-NT then translocates to mitochondria, disrupting their integrity and promoting mtDNA and mtROS release. GSDMD deficiency prevented ΔΨm loss, mtDNA/mtROS release, and IFN-β responses. Therefore, our findings establish a novel ESAT-6-GSDMD-mtDNA axis that drives type I IFN responses, providing critical insights into Mtb immune evasion strategies.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: